Panagiotopoulos C - Search Results

1

Wiedeman AM, Panagiotopoulos C, Devlin AM. Wiedeman AM, et al. Among authors: panagiotopoulos c. Appl Physiol Nutr Metab. 2021 Mar;46(3):193-204. doi: 10.1139/apnm-2020-0259. Epub 2020 Nov 23. Appl Physiol Nutr Metab. 2021. PMID: 33226841 Review.

2

Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications.

Panagiotopoulos C, Ronsley R, Davidson J. Panagiotopoulos C, et al. Can J Psychiatry. 2009 Nov;54(11):743-9. doi: 10.1177/070674370905401104. Can J Psychiatry. 2009. PMID: 19961662

3

Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics.

Devlin AM, Ngai YF, Ronsley R, Panagiotopoulos C. Devlin AM, et al. Among authors: panagiotopoulos c. Transl Psychiatry. 2012 Jan 24;2(1):e71. doi: 10.1038/tp.2011.68. Transl Psychiatry. 2012. PMID: 22832733 Free PMC article.

4

Childhood obesity and cardiovascular dysfunction.

Cote AT, Harris KC, Panagiotopoulos C, Sandor GG, Devlin AM. Cote AT, et al. Among authors: panagiotopoulos c. J Am Coll Cardiol. 2013 Oct 8;62(15):1309-19. doi: 10.1016/j.jacc.2013.07.042. Epub 2013 Aug 14. J Am Coll Cardiol. 2013. PMID: 23954339 Free article. Review.

5

Quetiapine treatment in youth is associated with decreased insulin secretion.

Ngai YF, Sabatini P, Nguyen D, Davidson J, Chanoine JP, Devlin AM, Lynn FC, Panagiotopoulos C. Ngai YF, et al. Among authors: panagiotopoulos c. J Clin Psychopharmacol. 2014 Jun;34(3):359-64. doi: 10.1097/JCP.0000000000000118. J Clin Psychopharmacol. 2014. PMID: 24633003

6

Effectiveness of an educational handbook in improving psychiatry resident knowledge of second-generation antipsychotics.

Gibson J, Nguyen D, Davidson J, Panagiotopoulos C. Gibson J, et al. Among authors: panagiotopoulos c. Acad Psychiatry. 2015 Apr;39(2):154-9. doi: 10.1007/s40596-014-0177-9. Epub 2014 Jul 4. Acad Psychiatry. 2015. PMID: 24994542

7

Interaction between the Val158Met catechol-O-methyltransferase gene variant and second-generation antipsychotic treatment on blood pressure in children.

Cote AT, Panagiotopoulos C, Devlin AM. Cote AT, et al. Among authors: panagiotopoulos c. Pharmacogenomics J. 2015 Feb;15(1):95-100. doi: 10.1038/tpj.2014.35. Epub 2014 Jul 22. Pharmacogenomics J. 2015. PMID: 25048416

8

Initial screening of children treated with second-generation antipsychotics points to an association between physical activity and insulin resistance.

Cote AT, Devlin AM, Panagiotopoulos C. Cote AT, et al. Among authors: panagiotopoulos c. Pediatr Exerc Sci. 2014 Nov;26(4):455-62. doi: 10.1123/pes.2014-0076. Pediatr Exerc Sci. 2014. PMID: 25372380

9

Obesity and arterial stiffness in children: systematic review and meta-analysis.

Cote AT, Phillips AA, Harris KC, Sandor GG, Panagiotopoulos C, Devlin AM. Cote AT, et al. Among authors: panagiotopoulos c. Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):1038-44. doi: 10.1161/ATVBAHA.114.305062. Epub 2015 Jan 29. Arterioscler Thromb Vasc Biol. 2015. PMID: 25633314 Review.

10

Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

Devlin AM, Panagiotopoulos C. Devlin AM, et al. Among authors: panagiotopoulos c. Pharmacogenomics. 2015;16(9):981-96. doi: 10.2217/pgs.15.55. Epub 2015 Jun 24. Pharmacogenomics. 2015. PMID: 26107755 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page